NFE2L2 and ischemic stroke: In addition, the mice treated with Tat‐Nrf2 exhibited a higher frequency of platform crossings and a longer duration spent in the target quadrant of the spatial probe trials in comparison to animals administered Tat‐Scr following ischemic stroke (Figure 9G,H).